GeneDx (WGS) has had the highest return since October 16, 2023 by a mid-cap US stock, returning 4,082.8%.
| ASSET | % RETURN |
|---|---|
GeneDx (WGS) | 4,082.77% |
Sezzle (SEZL) | 3,911.9% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 3,880% |
Regencell Bioscience (RGC) | 3,867.43% |
Dave (DAVE) | 3,746.68% |
D-Wave Quantum (QBTS) | 2,405.26% |
Ondas (ONDS) | 1,617.95% |
Rigetti Computing (RGTI) | 1,493.62% |
Praxis Precision Medicines (PRAX) | 1,203.24% |
Cidara Therapeutics (CDTX) | 1,084.46% |
Quantum Computing (QUBT) | 993.05% |
Terawulf (WULF) | 942.34% |
Celcuity LLC (CELC) | 897.48% |
Abivax SA American Depositary Shares (ABVX) | 855.34% |
Tutor Perini (TPC) | 786.95% |
Aura Minerals Inc Common Shares (AUGO) | 758.08% |
Perimeter Solutions (PRM) | 739.51% |
New Gold (NGD) | 724.75% |
Terns Pharmaceuticals (TERN) | 692.08% |
TMC the metals (TMC) | 671.59% |
Planet Labs PBC (PL) | 652.05% |
Arcutis Biotherapeutics (ARQT) | 639.95% |
CommScope (COMM) | 637.34% |
Nuvation Bio (NUVB) | 610% |
IAMGold (IAG) | 604.82% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
